miR-34c-5p induces LSC senescence through p53/p21-dependent CDK/Cyclin or p53-independent CDK/Cyclin pathways.LSC EV-mediated export of this factor inhibits this effect, leading to worse AML prognosis. Here, TP53 is linked to acute myeloid leukemia.